Big Pharma-backed Atalanta Therapeutics is ramping up for the clinical debut of the company’s lead epilepsy asset in the wake ...

Artificial intelligence is increasingly becoming a cornerstone in pharmaceutical research, with numerous companies leveraging ...

Scientists knew the disease ... They persuaded pharmaceutical company Genentech to back the testing. And in 2006, they got resounding results. Treatments targeting B cells were associated with ...

In this installment of “LC Troubleshooting,” Dwight Stoll touches on highlights from Pittcon 2025 talks, as well as ...

Modern biotechnology began in 1973 when scientists used recombination to ... molecule production that culminated in the founding of Genentech, the first publicly-owned biotech company, in 1976.

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on Saturday won a prestigious Breakthrough Prize, the award nicknamed the “Oscars of ...

Alterome Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, today announced ...

The company has a long history of leading HR policy changes. Now it is kowtowing to the president's anti-DEI stand.

A week after President Trump instituted broad tariffs on imports during his “Liberation Day,” he abruptly announced yesterday ...